+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register

Global Spinal Cord Stimulation Devices Market will Reach 2.8 Billion USD in 2025

Author: QYResearch | Publish date: 2018-06-03 | Views: 223
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.


A spinal cord stimulator (SCS) device is surgically placed under your skin and sends a mild electric current to your spinal cord. A small wire carries the current from a pulse generator to the nerve fibers of the spinal cord. When turned on, the SCS stimulates the nerves in the area where your pain is felt. Pain is reduced because the electrical pulses modify and mask the pain signal from reaching your brain.


In the last several years, global market of spinal cord stimulation devices was experienced an upward trend rapidly, with an average growth rate of 5.51%. In 2017, global revenue of spinal cord stimulation devices is nearly 2.15 billion USD; the actual Sales are about 116 K Unit.


The classification of spinal cord stimulation devices includes rechargeable type and Non-Rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017.


Spinal cord stimulation devices is widely used in failed back surgery syndrome, complex regional pain syndrome, chronic pain and other field. The most proportion of spinal cord stimulation devices is for failed back surgery syndrome, and the proportion in 2017 is 42%.


North America is the largest supplier of Spinal Cord Stimulation Devices, with a production market share nearly 87% in 2017. Europe is the second largest supplier of Spinal Cord Stimulation Devices, enjoying production market share nearly 13% in 2017.


North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.


Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro,

Nuvectra are the leaders of the industry. and Top 3 account for around 78% of the total market share. These existing companies are making investments in several research activities to launch new devices.


The Global Spinal Cord Stimulation Devices Market Research Report 2018 report released by QYResearch provides a basic overview of the Spinal Cord Stimulation Devices industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.


The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Spinal Cord Stimulation Devices industry development trends and marketing channels were analyzed. Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.


Click to view the full report



We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients